Envita Medical Center has been treating cancer for nearly two decades, in that time they have tested and reviewed thousands of patients and their potential causes of cancer. This accumulation of clinical data has allowed Envita to notice a recurring trend between cancer patients and underlying chronic infections, leading to a published paper on the subject in the 2014 Open Journal of Medical Microbiology titled Cancer and Infectious Causes. Data is very clear that specific cancers are linked to certain infections, many people are aware that infections like HPV can lead to cervical cancer, and Epstein Barr can cause Hodgkin’s Lymphoma. What you may not know is that recent data suggests 25% of all infections may potentially lead to cancer and this statistic, in our clinical experience, could be an underestimate. Patients with chronic Lyme disease may not realize the potential cancer risk they are exposing themselves to. A surprisingly high number of Envita’s patients with late-stage cancer test positive for Lyme disease as well as its primary or secondary coinfections.
Lyme Disease’s Role in Cancer Development
Lyme disease is a complicated bacterial infection that is often seen accompanied by many other co-infections, this heightened number of infections could be making patients more susceptible to cancer. Infections have been shown to have three major modes of either causing or assisting in tumor growth, they cause inflammation, depress the immune system, and they can alter DNA causing mutations in the cell. Fortunately, Envita has developed patient specific and targeted treatment plans for Lyme disease and many of its coinfections, reducing the risk of developing cancer from infections for their patients.
Lyme disease patients may be very susceptible to cancer as Lyme can directly or indirectly cause all three of the mechanics that lead to tumor growth. Lyme disease and it coinfections directly cause inflammation of muscle and nerve tissue through endotoxins, biotoxins, and neurotoxins released by the bacterial infection. Lyme and its co-infections can severely depress the immune system making the body more susceptible to viral infections which can alter cellular DNA leading to cancer in a process known as oncogenesis. It is important to understand that Lyme disease is rarely seen alone and is almost always accompanied by other infections which must be addressed for proper treatment and cancer prevention.
Lyme Disease and Co-Infections Assist in Immune Suppression That May Lead to Cancer
When a tick bites and passes Lyme disease, there is a high chance it is going to pass whatever viral, fungal, parasitic, and bacterial infections it has as well. After Lyme and the co-infections have a chance to propagate in the patient’s body the immune system will start to become over taxed trying to fight off the multitude of infections and will even start to attack the body’s own cells as the biotoxins and endotoxins confuse it. This leads to a highly compromised immune system that is now susceptible to opportunistic infections that intern further depress the immune system. A healthy immune system identifies and destroys a countless number of preliminary cancer cells every day; cancer cell growth is a natural process that occurs when a cell’s DNA begins to degrade. Normally, the immune system identifies these cancer cells and kills them before they reproduce spreading their mutated genes. In simple terms, when the immune system is compromised by Lyme and its co-infections, it can become increasingly more unlikely to rid the body of these naturally occurring cancer growths, making Lyme disease patients more susceptible to developing cancer. Lyme does not only depress the immune system though; it also employs endotoxins, biotoxins and neurotoxins that cause chronic inflammation which assists in the spread of cancer.
The borrelia spirochete is depicted here giving off various endotoxins, neurotoxins, and biotoxins to inhibit neurological and hormonal signaling to shut down the body’s defense mechanisms so the infection can feed on the body’s healthy tissue.
Inflammation and Carcinogenic Toxins
Inflammation can cause an environment that has an increase in oxidative stress, free-radicals caused by the oxidative stress create chain reactions within molecules in the body leading to many problems including the damage of cells. If these free-radical reactions occur in the nucleus of the cell where the DNA resides it may result in cancer. Lyme and its co-infections release various toxins into the body, the job of these toxins is to inhibit neurological and hormonal signaling to shut down the body’s defense mechanisms so the infection can feed on the body’s healthy tissue. The inflammation caused by the endotoxins and neurotoxins from Lyme disease and its coinfections may leave the patient more susceptible to develop cancer by producing an environment that is more likely to experience oxidative stress and may lead to abnormal gene regulation that could result in cancer. Early signals of Lyme disease linked inflammation may be seen in the brain and are common in patients experiencing Neuroborreliosis. A condition where borrelia, the Lyme disease bacteria, crosses the blood-brain barrier and enters the brain. Lyme is a complicated disease that can lead to cancer through inflammation and carcinogenic toxins but it can also make the body more susceptible to viruses that can cause oncogene changes resulting in cancer formation.
Oncogene changes are changes to a gene that may result in cancer. Viruses are known to cause oncogenesis because they infiltrate cells and insert their own RNA to reprogram the cell and make it a factory for creating more viruses. This changing of the cells genes by the virus may result in the cell becoming cancerous. It is common for people to have viral infections that are suppressed and remain dormant in a healthy immune system with no signs or symptoms of infection. However, these pre-Lyme viruses can become active when the immune system becomes suppressed by the disease and its co-infections. Lyme disease has many actions from which it can make the body more susceptible to viral infection and intern oncogene changes and cancer, but with proper diagnosis and treatment of Lyme disease and its co-infections the risk of developing cancer can be mitigated when the clinician knows what to look for.